Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)

By BioHealth Innovation, Inc. (BHI)

Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery, and Wall Street’s Views on this Exciting Science.

Listen to Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94) now.

Listen to Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94) in full in the Spotify app